Long-haul Covid patients put hope in experimental drugs
Representational image
Sumathi Reddy
, The Wall Street Journal
Share Via
Read Full Story
Patrick Varnes has suffered from shortness of breath, fatigue and headaches for about six months since being diagnosed with Covid at the end of June. The 41-year-old financial director in Atlanta says he has tried nearly 30 different supplements, acupuncture and a steroid.
When he heard in an online support group about an experimental drug intended to treat long-term symptoms of Covid, he reached out to a doctor, and hopes to participate in a clinical trial if the FDA approves one.
Updated Dec. 21, 2020 6:52 pm ET
Patrick Varnes has suffered from shortness of breath, fatigue and headaches for about six months since being diagnosed with Covid at the end of June. The 41-year-old financial director in Atlanta says he has tried nearly 30 different supplements, acupuncture and a steroid.
When he heard in an online support group about an experimental drug intended to treat long-term symptoms of Covid, he reached out to a doctor, and hopes to participate in a clinical trial if the FDA approves one.
“After six months of living in an internal prison, I need to try it,” says Mr. Varnes. “I really, really hope it works.”